Publications by authors named "Omar Kayaleh"

Claim this Profile
P
Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery.
Lisa A Kachnic, Kathryn Winter, Mohan Suntharalingam, David Ilson, André Konski, Omar Kayaleh

Qual Life Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma.
Ruchi Singhal, Sherise C Rogers, Ji-Hyun Lee, Brian Ramnaraign, Ilyas Sahin, Omar Kayaleh

Future Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypercalcemia Resulting from Necrotizing Leiomyoma in a Pregnant Female.
Jacqueline Kropf, Mai Vo, Sarah Cheyney, Omar Kayaleh, Jeannie McWhorter

Am J Case Rep· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction.
Mitchell Cheung, Yuwaraj Kadariya, Jacqueline Talarchek, Jianming Pei, Jill A Ohar, Omar R Kayaleh

Cancer Lett· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study.
Bohuslav Melichar, Antoine Adenis, A Craig Lockhart, Jaafar Bennouna, E Claire Dees, Omar Kayaleh

Lancet Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful gestation and delivery using clopidogrel for secondary stroke prophylaxis: a case report and literature review.
Christopher R Reilly, Ana Cuesta-Fernandez, Omar R Kayaleh

Arch Gynecol Obstet· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of specificity protein transcription factors in pancreatic cancer and their association in prognosis and therapy.
Umesh T Sankpal, Pius Maliakal, Debashish Bose, Omar Kayaleh, Daniel Buchholz

Curr Med Chem· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma.
Andrew H Ko, Hagop Youssoufian, Jayne Gurtler, Karel Dicke, Omar Kayaleh

Invest New Drugs· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis